| 纯度 | >85%SDS-PAGE. |
| 种属 | Human |
| 靶点 | THTPA |
| Uniprot No | Q9BU02 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 2-230aa |
| 氨基酸序列 | AQGLIEVER KFLPGPGTEE RLQELGGTLE YRVTFRDTYY DTPELSLMQA DHWLRRREDS GWELKCPGAA GVLGPHTEYK ELTAEPTIVA QLCKVLRADG LGAGDVAAVL GPLGLQEVAS FVTKRSAWKL VLLGADEEEP QLRVDLDTAD FGYAVGEVEA LVHEEAEVPT ALEKIHRLSS MLGVPAQETA PAKLIVYLQR FRPQDYQRLL EVNSSRERPQ ETEDPDHCLG |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于THTPA重组蛋白的3篇示例参考文献(注：THTPA相关研究较少，以下内容为虚构示例，实际文献需通过学术数据库检索)：
---
1. **文献名称**：Cloning and Functional Characterization of Recombinant THTPA Protein in E. coli
**作者**：Zhang L, et al.
**摘要**：本研究成功将THTPA基因克隆至大肠杆菌表达系统，通过优化诱导条件获得可溶性重组蛋白。纯化后的THTPA在体外表现出ATP酶活性，并证实其参与细胞能量代谢调控，为后续功能研究奠定基础。
---
2. **文献名称**：Structural Analysis of THTPA Reveals a Novel Protein Folding Motif
**作者**：Smith J, et al.
**摘要**：通过X射线晶体学解析了重组THTPA的三维结构，发现其具有独特的α-螺旋-β折叠复合结构域。该结构特征可能解释THTPA在信号转导中的分子相互作用机制。
---
3. **文献名称**：THTPA Recombinant Protein Enhances Neuronal Differentiation in vitro
**作者**：Wang Y, et al.
**摘要**：利用哺乳动物细胞表达系统制备高纯度THTPA重组蛋白，实验表明其可激活MAPK通路，促进神经干细胞向神经元分化，提示THTPA在神经再生领域的潜在应用价值。
---
**建议**：实际研究中，建议通过PubMed、Web of Science等平台，以“THTPA recombinant protein”“THTPA gene expression”等关键词检索最新文献。若THTPA为特定领域缩写，需明确全称(如：Tetrahydrobiopterin biosynthesis protein A)。
**Background of THTPA Recombinant Protein**
THTPA (Tetrahedral Hemolysin Toxin-Pore Forming Protein A) recombinant protein is a genetically engineered variant derived from naturally occurring bacterial toxins, particularly those produced by certain pathogenic bacteria. These proteins belong to the pore-forming toxin (PFT) family, which disrupts host cell membranes by creating transmembrane pores, leading to cell lysis and contributing to bacterial virulence. THTPA is characterized by its unique tetrahedral structural arrangement, enabling efficient membrane penetration and oligomerization.
The interest in recombinant THTPA stems from its dual role as a virulence factor and a potential tool in biotechnology. Studying its mechanism aids in understanding bacterial pathogenesis and developing antimicrobial strategies. Recombinant production allows for controlled expression in heterologous systems (e.g., *E. coli* or yeast), ensuring high purity and scalability for research or therapeutic applications.
In biotechnology, THTPA’s pore-forming ability has been exploited for targeted drug delivery, biosensing, or cancer therapy, where controlled membrane disruption is advantageous. Structural studies of recombinant THTPA, facilitated by techniques like X-ray crystallography, provide insights into its conformational dynamics, guiding engineering efforts to modulate its activity or stability.
Furthermore, recombinant THTPA serves as an antigen in vaccine development, leveraging its immunogenic properties to elicit protective immune responses. Safety-modified variants are also explored to neutralize its toxicity while retaining functional features.
Overall, THTPA recombinant protein bridges microbiology, structural biology, and applied biotechnology, offering avenues for both understanding microbial pathogenicity and developing novel biomedical interventions. Its engineered production underscores the convergence of synthetic biology and infectious disease research.
(Word count: 249)
×
